Plasma Cell Dyscrasia: A Case Series of a Masquerader

Plasma Cell Dyscrasia: A Case Series of a Masquerader

Plasma cell dyscrasia is a result of an abnormal clonal proliferation of plasma cells. These cells arise from B cells in the bone marrow and produce immunoglobulins. Multiple myeloma is a type of plasma cell dyscrasia that commonly presents with symptoms secondary to hypercalcemia, hyperviscosity, r...

Full description

Bibliographic Details
Main Authors:	Nikhil Elenjickal, Chaitanya Kulkarni, Rashmi Algeri, Jatin Kothari, Alan Almeida, Rashika Sirsat
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2022-01-01
Series:	Saudi Journal of Kidney Diseases and Transplantation
Online Access:	http://www.sjkdt.org/article.asp?issn=1319-2442;year=2022;volume=33;issue=3;spage=492;epage=497;aulast=Elenjickal

Similar Items

Rheumatic masks of plasma cell dyscrasias
by: Vladimir Ivanovich Vasilyev, et al.
Published: (2012-04-01)

A case of plasma cell dyscrasia presenting as nonscarring alopecia
by: Benjamin Nia, MD, et al.
Published: (2021-09-01)

The Non-Coding RNA Landscape of Plasma Cell Dyscrasias
by: Eugenio Morelli, et al.
Published: (2020-01-01)

Leptomeningeal isolated infiltration in plasma cell dyscrasia associated to HIV
by: Flávia Sprenger, et al.
Published: (2022-12-01)

Differential diagnosis of plasma cell dyscrasias in rheumatological practice
by: V I Vasilyev, et al.
Published: (2010-12-01)

Differential diagnosis of plasma cell dyscrasias in rheumatological practice
by: V I Vasilyev, et al.
Published: (2010-12-01)

Plasma Cell Dyscrasia; LCDD vs Immunotactoid glomerulopathy
by: Jabur Wael, et al.
Published: (2008-01-01)

Pulmonary Vascular Disease Due to Plasma Cell Dyscrasia
by: Indranee Rajapreyar, MD, et al.
Published: (2021-02-01)

Crusted scabies in systemic sclerosis with plasma cell dyscrasia
by: Balkrishna P Nikam, et al.
Published: (2018-01-01)

A descriptive study of plasma cell dyscrasias in Egyptian population
by: Neemat M. Kassem, et al.
Published: (2014-06-01)

Clinical and Biological Characteristics of Medullary and Extramedullary Plasma Cell Dyscrasias
by: Snjezana Janjetovic, et al.
Published: (2021-07-01)

COVID-19 vaccine immune response and plasma cell dyscrasia
by: Amnuay Kleebayoon, et al.
Published: (2023-11-01)

Free Kappa and Lambda Light Chains in Plasma Cell Dyscrasias
by: Clementine YF Yap MT(ASCP), DLM(ASCP), et al.
Published: (2011-03-01)

Hematopoietic Cell and Renal Transplantation in Plasma Cell Dyscrasia Patients
by: Olga Baraldi, et al.
Published: (2016-06-01)

The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia
by: Terry Golombick, et al.
Published: (2008-03-01)

The fundus findings in blood dyscrasias
by: Kataria V, et al.
Published: (1983-12-01)

Plasma cell dyscrasia presenting as retro-orbital mass - lessons to learn?
by: Srinivas
Published: (2014-06-01)

The Role of the Gut Microbiome in Pathogenesis, Biology, and Treatment of Plasma Cell Dyscrasias
by: Marcin Jasiński, et al.
Published: (2021-10-01)

Plasma cell dyscrasia: monoclonal gammopathies, AL-amyloidosis, multiple myeloma Clinical case study
by: V. V. Cherepanova, et al.
Published: (2023-03-01)

NK cells and CD38: Implication for (Immuno)Therapy in Plasma Cell Dyscrasias
by: Renato Zambello, et al.
Published: (2020-03-01)

C-src enriched serum microvesicles are generated in malignant plasma cell dyscrasia.
by: Giuseppe Di Noto, et al.
Published: (2013-01-01)

Plasma cell myeloma masquerading as scleromyxedema
by: Varun Victor, et al.
Published: (2019-01-01)

The exploration of B cell maturation antigen expression in plasma cell dyscrasias beyond multiple myeloma
by: Yanjie Xu, et al.
Published: (2023-02-01)

Correlation of plasma cell assessment by phenotypic methods and molecular profiles by NGS in patients with plasma cell dyscrasias
by: Ekaterina Rebmann Chigrinova, et al.
Published: (2022-09-01)

COVID-19 vaccine immune response in patients with plasma cell dyscrasia: a systematic review
by: Unaiza Faizan, et al.
Published: (2023-08-01)

Utility of CD200 expression by flow cytometry in lymphoproliferative disorders and plasma cell dyscrasias
by: Pavuluri Divya, et al.
Published: (2023-01-01)

Neutrophil Extracellular Traps (NETs) and Hypercoagulability in Plasma Cell Dyscrasias—Is This Phenomenon Worthy of Exploration?
by: Olga Ciepiela, et al.
Published: (2021-11-01)

Histiocytic Glomerulopathy With Noncrystalline Inclusion Associated With IgG-Kappa Plasma Cell Dyscrasia
by: Ai Katsuma, et al.
Published: (2023-05-01)

Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias
by: Aldo M Roccaro, et al.
Published: (2008-09-01)

Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myeloma
by: Jinhuan Xu, et al.
Published: (2018-10-01)

Recalcitrant cutaneous pyoderma gangrenosum with pulmonary involvement resolved with treatment of underlying plasma cell dyscrasia
by: Tyler A. Hooton, MD, et al.
Published: (2021-03-01)

Urethral Caruncle Masquerading a Primary Amelanotic Melanoma, the Risk of a Poor Prognosis due to Misdiagnosis
by: Paola Algeri, et al.
Published: (2022-09-01)

Uveitis masquerade syndromes: A case series
by: Sudha K Ganesh, et al.
Published: (2022-01-01)

Masqueraders of pneumonia in children: A case series
by: Hardeep Kaur, et al.
Published: (2024-01-01)

Acquired Isolated Factor VII Deficiency in Plasma Cell Dyscrasias: A Brief Presentation of Two Plasma-Cell-Leukemia-Related Cases and Review of Literature
by: Anna Furlan, et al.
Published: (2023-09-01)

Impact of polypharmacy on inducing blood dyscrasias in clozapine treated patients
by: M. Shiri, et al.
Published: (2022-06-01)

Dental surgical care in blood dyscrasias patients: an epidemiological study
by: Lorenzzo De Angeli CESCONETTO, et al.
Published: (2021-11-01)

Oral manifestations of white blood cell dyscrasias with emphasis on their management
by: Amritha James, et al.
Published: (2021-01-01)

Plasma cell dyscrasia behavior in a referral hospital in southern Colombia: younger, clinically and paraclinically worse than reported
by: kenny buitrago-toro, et al.
Published: (2020-12-01)

Hierarchical Involvement of Myeloid-Derived Suppressor Cells and Monocytes Expressing Latency-Associated Peptide in Plasma Cell Dyscrasias
by: Tamar Tadmor, et al.
Published: (2018-05-01)